All companies
Visit website
Vivoo
OperatingVivosens Inc.
Healthcare · San Francisco, CA · Founded 1905
Woman-founded
Personal wellness advice through at-home urine sample analysis
Post-money valuation ⓘ
$7.6M
As of Sep 2020 · from Vivoo Stock 2 · pre-money + amount raised, not a traded price
Total raised
$1,143,101
Across 3 rounds since 2020
Latest share price
$0.37
Vivoo Stock 2 offering price
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.6M
post-money
Vivoo Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $143.1K / $500KInvestors 538Post-money $7.6M
Raised $500K / $500KInvestors 2,076
Reg CF annual-report compliance
Delinquent
Filed 2 of 7 annual reports (FY2019–FY2025)
Missing: 2021, 2022, 2023, 2024, 2025
2,076 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001793344DEShare price $0.37
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.